SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.04.15 | Roche Neutral | UBS AG | |
| 08.04.15 | Novartis buy | UBS AG | |
| 07.04.15 | Roche Neutral | Citigroup Corp. | |
| 01.04.15 | Novartis Equal weight | Barclays Capital | |
| 01.04.15 | Roche overweight | Barclays Capital | |
| 31.03.15 | Roche Outperform | Credit Suisse Group | |
| 31.03.15 | Roche overweight | JP Morgan Chase & Co. | |
| 04.03.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.15 | Roche Outperform | BNP PARIBAS | |
| 04.03.15 | Novartis Outperform | BNP PARIBAS | |
| 03.03.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.03.15 | Novartis buy | UBS AG | |
| 23.02.15 | BB Biotech Verkaufen | Independent Research GmbH | |
| 23.02.15 | Roche Neutral | UBS AG | |
| 20.02.15 | Novartis buy | Jefferies & Company Inc. | |
| 20.02.15 | Roche buy | Jefferies & Company Inc. | |
| 12.02.15 | Roche overweight | Barclays Capital | |
| 09.02.15 | Novartis buy | Citigroup Corp. | |
| 09.02.15 | Roche Neutral | Citigroup Corp. | |
| 09.02.15 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.15 | Roche Hold | Kepler Cheuvreux | |
| 29.01.15 | Roche buy | Deutsche Bank AG | |
| 29.01.15 | Roche overweight | Morgan Stanley | |
| 28.01.15 | Novartis neutral | Morgan Stanley | |
| 28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.01.15 | Novartis Hold | Deutsche Bank AG | |
| 28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.15 | Novartis Halten | Independent Research GmbH | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Roche Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 22.01.15 | Roche Neutral | UBS AG | |
| 21.01.15 | Novartis neutral | Morgan Stanley | |
| 21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.01.15 | Novartis Equal-Weight | Morgan Stanley |